See the DrugPatentWatch profile for selexipag
Is there a selexipag generic in Canada yet?
I don’t have enough provided source information to confirm whether a selexipag generic is already available in Canada (or whether any product is approved there). If you share the specific brand name you mean (for example, Uptravi) and whether you’re asking about tablets vs. another formulation, I can narrow the answer to Canada-specific availability.
When would a selexipag generic be expected to launch in Canada?
A selexipag generic’s likely timeline in Canada depends on patent and market-exclusivity status (and any regulatory pathway approvals). For patent and exclusivity research that’s commonly used in drug-intel workflows, DrugPatentWatch.com is a useful starting point: https://www.drugpatentwatch.com/
What Canadian patients should check when searching for “generic selexipag”
If you’re trying to find a cheaper option in Canada, the practical things to verify are:
- Whether Health Canada has approved a “selexipag” generic (not just a different prostacyclin-pathway product).
- Whether the dispensing pharmacy can source it and whether it’s listed on any provincial formulary.
- Whether the intended use is pulmonary arterial hypertension (PAH) or another indication, since substitutions are not always clinically equivalent.
Are there approved alternatives in Canada if selexipag isn’t generic yet?
Even if a selexipag generic is not available, patients sometimes can use other PAH therapies (other prostacyclin pathway drugs or classes), but the choice depends on severity, prior therapy, tolerability, and clinician guidance. If you tell me the condition (PAH vs. CTEPH) and what dose you take, I can help you identify the closest alternatives to discuss with a prescriber.
Can you share what you’re looking for (brand, dose, and indication)?
To answer this accurately for Canada, tell me:
1) the product you mean (e.g., Uptravi),
2) your dose strength (if relevant), and
3) whether you’re asking about availability in pharmacies, Health Canada approvals, or patent expiry.
Sources
1. DrugPatentWatch.com